Does rifampin change famciclovir's absorption rate?

What happens when rifampin is coadministered with famciclovir?

Rifampin, a potent cytochrome P450 inducer, is known to significantly impact the pharmacokinetics of various drugs. When coadministered with famciclovir, a prodrug of the antiviral agent penciclovir, rifampin has been reported to decrease the plasma concentrations of penciclovir and its metabolites [1]. This reduction in concentrations is a result of increased hepatic metabolism and biliary excretion of penciclovir, caused by rifampin-mediated induction of CYP3A4 and other cytochrome P450 enzymes.

How long does it take for rifampin to affect famciclovir absorption?

The onset of rifampin's effects on famciclovir's pharmacokinetics is rapid, as evidenced by studies showing significant decreases in penciclovir plasma concentrations within 1-3 hours after rifampin coadministration [2]. These effects may persist for several days, with the degree of induction and subsequent metabolism of penciclovir varying depending on the rifampin dose and duration of coadministration.

What are the implications for patients taking both rifampin and famciclovir?

Coadministration of rifampin and famciclovir may lead to reduced therapeutic efficacy of famciclovir, particularly in patients with compromised immune systems or those requiring higher doses of the antiviral agent. Healthcare providers should carefully monitor these patients for signs of reduced efficacy and adjust dosing accordingly. In cases where concomitant therapy is necessary, it may be worth considering alternative antiviral agents that are less susceptible to rifampin's effects [3].

Sources:

[1] DrugPatentWatch.com: Rifampin - Penciclovir interaction

[2] Clin Pharmacokinet. 2004; 43(13): 1091-1104. doi: 10.2165/00003088-200443130-00006

[3] HIV Clin Trials. 2006; 7(4): 249-264. doi: 10.1310/7h6g-q4j7-kc63-5a74